Click Here to Join Session

Zoster is a common diagnosis, and its prevalence increases with age and states of immunodeficiency. Two main vaccines to prevent zoster are currently available – Zoster live attenuated vaccine, and zoster recombinant vaccine. In this talk we will discuss the clinical presentation of zoster, its various, sometimes life threatening, complications, and the two available vaccines: their efficacy in clinical trials and the populations for which they are indicated.

Topics

• Epidemiology, risk factors and complications of zoster
• The vaccines to prevent Zoster: efficacy, pros and cons and indications

About Lecturer Dr. David Shasha

Dr. David Shasha is a specialist of infectious diseases and internal medicine at the Tel-Aviv Sourasky Medical Center in Tel-Aviv, Israel, and the chief consultant of infectious diseases in two Israeli HMO’s (Leumit and Meuhedet). He completed his training in internal medicine and infectious diseases at Hadassah medical center in Jerusalem, and a post-doctoral fellowship of HIV immunology at the Ragon institute of MGH, MIT and Harvard, Cambridge, MA, USA. He is an active clinician both at the hospital (working with immunocompromised patients) and in the community, and he is also involved in research of important questions in infectious diseases including the safety of COVID vaccines, sexually transmitted infections, and the use of laboratory tests and antibiotics in the community.

About the Moderator Dr Ferdinando Petrazzuoli

Ferdinando Petrazzuoli has been a family doctor in his native, rural, village in Southern Italy for 35 years. He is a postdoctoral researcher at the Center for Primary Health Care Research, Department of Clinical Sciences in Malmo, Lund University, Sweden. He obtained his PhD at the Center for Primary Health Care Research, Department of Clinical Sciences in Malmo, Lund University, Sweden in 2019 with the thesis: Dementia management in European Primary Care. He has a Master of Science (MSc) in Primary Care & General Practice from the University of Ulster (United Kingdom) (2008). From June 2022 on  WONCA Europe Executive Board member at large (EURIPA). From 2010 to 2019 he was a member of the Executive Board of the European General Practice Research Network (EGPRN) which is a network within WONCA Europe. He completed three terms as vice-chair and is responsible for the Web Based Research Course. In 2017 he was nominated to be chair of the Dementia group in the Working Party on Mental Health of WONCA WORLD. In 2015 he was nominated to the Euripa Executive Board, and became Chair of the EURIPA Scientific Board. Euripa is the European Rural and Isolated Practitioners Association and is a network within WONCA Europe. In 2022 he was nominated member at large for the WONCA Working Party on Mental Health. 2018-2020 Involved in Fall-in-Age project: Innovative Training for Technology-based Frailty and Falls Management, an Eramus+ granted Project Project Reference: 2018-1-PT01-KA203-047343. https://fallinage.ist.utl.pt/index.html

This webinar is supported by an unrestricted educational grant from GSK.